Welcome to our dedicated page for 908 Devices SEC filings (Ticker: MASS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for 908 Devices Inc. (NASDAQ: MASS) provides access to the company’s official U.S. Securities and Exchange Commission disclosures, alongside AI-powered summaries that help explain the contents of each document. As an emerging growth company listed on The NASDAQ Global Market, 908 Devices files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, among other documents.
In its filings, 908 Devices reports financial performance and segment details related to its portfolio of purpose-built handheld devices for chemical analysis. Investors can review product revenue, service and contract revenue, OEM and funded partnership revenue, recurring revenue associated with its installed base, and information on cost of revenue, operating expenses and net income or loss from continuing operations. The company also discloses non-GAAP metrics such as adjusted gross profit, adjusted gross margin and adjusted EBITDA, along with reconciliations to the nearest GAAP measures.
Form 8-K filings highlight material events such as quarterly earnings releases and changes in the Board of Directors. For example, recent 8-Ks have furnished press releases announcing financial results for specific quarters and documented the resignation of a director and appointment of a new director with extensive experience in nuclear, chemical and biological defense programs. These filings also confirm the company’s listing details and emerging growth company status.
Through this page, users can also monitor equity and governance disclosures, including information on non-employee director compensation, stock option and incentive plans, and any future insider transaction reports on Form 4 when available. Stock Titan’s AI tools summarize lengthy filings, highlight key figures and definitions, and surface important changes in revenue composition, operating expenses, contingent consideration, restructuring charges and other items that affect 908 Devices’ financial profile.
By combining real-time EDGAR updates with plain-language AI explanations, this filings hub helps readers quickly understand how 908 Devices is performing, how it uses non-GAAP measures, and how governance and strategic decisions are reflected in its regulatory record.
First Light Asset Management, LLC and Mathew P. Arens have disclosed significant passive ownership stakes in 908 Devices Inc. First Light reports beneficial ownership of 5,964,739 common shares, representing 16.48% of the company. Arens reports beneficial ownership of 6,184,739 shares, or 17.09% of the class.
The filing explains that First Light holds shares as an investment adviser to separately managed accounts and private funds, while Arens controls First Light and also owns additional shares directly and in joint accounts. They certify the holdings are in the ordinary course of business and not for the purpose of influencing control of 908 Devices.
State Street Corporation has reported beneficial ownership of 596,294 shares of 908 Devices Inc common stock, representing 1.6% of the class as of 12/31/2025. These shares are held with shared voting power over 564,044 shares and shared dispositive power over 596,294 shares.
Through subsidiary SSGA Funds Management, Inc., the group reports beneficial ownership of 134,786 shares, or 0.4% of the class, all with shared voting and dispositive power. The securities are certified as held in the ordinary course of business, not for the purpose of changing or influencing control of 908 Devices.
908 Devices Inc. director Christopher D. Brown reported the settlement of three batches of restricted stock units (RSUs) into Common Stock on February 1, 2026. RSUs covering 5,027, 7,418, and 10,992 shares converted into the same number of Common shares at an exercise price of $0 per share.
Following these vesting events, Brown directly beneficially owns 985,559 shares of Common Stock and 21,982 RSUs. The RSU awards vest in four substantially equal annual installments on anniversary dates following February 1, 2022, February 1, 2023, and February 1, 2024, subject to his continued service.
908 Devices Inc. President and CEO Kevin J. Knopp reported equity compensation activity and a tax-related share sale. On February 1, 2026, several Restricted Stock Units vested and were settled for 11,255, 13,449, 17,007, and 66,288 shares of common stock, increasing his direct holdings to 830,732 shares.
On February 2, 2026, Knopp sold 34,764 shares of common stock at a weighted average price of $6.18 solely to cover tax withholding from the RSU vesting, leaving 795,968 shares held directly. He also received 205,978 new RSUs and a stock option for 90,043 shares at a $6.19 exercise price, which begin vesting on February 1, 2027. Separately, 541,223 shares are held indirectly by The Kevin J. Knopp Irrevocable Trust of 2018, for which his brother-in-law serves as trustee with sole voting and dispositive control.
908 Devices Inc. Chief Financial Officer Joseph H. Griffith IV reported a mix of equity grants, vesting and a tax-related sale. On February 1, 2026, several tranches of RSUs vested and settled into 5,102, 10,306, 11,260 and 43,473 shares of common stock. On February 2, 2026, he received 121,164 new RSUs and a stock option for 52,967 shares with a $6.19 exercise price. That same day, he sold 23,175 shares at a weighted average of $6.18 solely to cover tax withholding triggered by the RSU vesting, under a required “sell to cover” arrangement. After these transactions, he directly held 139,896 shares of common stock.
Director Mark Spoto of 908 Devices Inc. reported family-related movements of common stock. On 10/14/2025, 928 shares were acquired at
908 Devices Inc. furnished a Form 8-K to report that it has announced preliminary financial results for the fourth quarter and fiscal year ended December 31, 2025. The company issued a press release on January 20, 2026 describing these preliminary results, which is included as Exhibit 99.1.
The information about results of operations and financial condition is being furnished under Item 2.02 of the Form 8-K and is not considered filed for purposes of certain liability provisions of the federal securities laws, unless specifically incorporated by reference in other filings.
908 Devices Inc. (MASS) reported Q3 2025 results. Revenue was $14.0 million, slightly below $14.5 million a year ago, while year-to-date revenue rose to $38.8 million from $33.4 million. Gross profit for the quarter was $7.4 million.
Operating expenses reflected a $10.7 million increase in the fair value of contingent consideration, driving a Q3 loss from continuing operations of $14.9 million. Year-to-date loss from continuing operations was $37.7 million.
The company completed the sale of its Desktop Portfolio to Repligen, recording a $56.1 million gain
Liquidity strengthened with cash and cash equivalents of $62.8 million and marketable securities of $49.3 million at September 30, 2025. Deferred revenue was $18.3 million. A current contingent consideration liability of $23.0 million reflects updated fair value tied to prior acquisitions.
Shares outstanding were 36,118,576 at September 30, 2025; as of November 5, 2025, they were 36,192,978.
908 Devices Inc. (MASS) furnished a press release announcing its financial results for the third quarter ended September 30, 2025. The release is attached as Exhibit 99.1 to a Form 8-K dated November 10, 2025.
The information under Item 2.02 is being furnished, not filed, under the Exchange Act. MASS’s common stock trades on The NASDAQ Global Market.
908 Devices Inc. Chief Financial Officer Joseph H. Griffith IV reported planned stock sales under a Rule 10b5-1 trading plan. The filings show sales on